Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 126,367Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Eligard

02 2Leuplin/Enantone

03 5Leuprorelin

04 8Lupron

PharmaCompass

01

Brand Name : Lupron

arrow
Peptide Therapy Summit
Not Confirmed

Leuprolide Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 752

2019 Revenue in Millions : 887

Growth (%) : -15

Abbvie Company Banner

02

Brand Name : Lupron

arrow
Peptide Therapy Summit
Not Confirmed

Leuprolide Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 783

2020 Revenue in Millions : 752

Growth (%) : 4

Abbvie Company Banner

03

Brand Name : Lupron

arrow
Peptide Therapy Summit
Not Confirmed

Leuprolide Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 829

2016 Revenue in Millions : 821

Growth (%) : 1

Abbvie Company Banner

04

Brand Name : Lupron

arrow
Peptide Therapy Summit
Not Confirmed

Leuprolide Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2016 Revenue in Millions : 821

2015 Revenue in Millions : 826

Growth (%) : -1

Abbvie Company Banner

05

Brand Name : Lupron

arrow
Peptide Therapy Summit
Not Confirmed

Leuprolide acetate

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 778

2014 Revenue in Millions : 826

Growth (%) : 6%

Abbvie Company Banner

06

Brand Name : Lupron

arrow
Peptide Therapy Summit
Not Confirmed

Leuprolide Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 892

2017 Revenue in Millions : 829

Growth (%) : 8%

Abbvie Company Banner

07

Brand Name : Lupron

arrow
Peptide Therapy Summit
Not Confirmed

Leuprolide Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 887

2018 Revenue in Millions : 892

Growth (%) : -1

Abbvie Company Banner

08

Brand Name : Lupron

arrow
Peptide Therapy Summit
Not Confirmed

Leuprolide acetate

Main Therapeutic Indication : Oncology

Currency : USD

2014 Revenue in Millions : -0.90%

2013 Revenue in Millions :

Growth (%) :

Abbvie Company Banner

09

Brand Name : Leuprorelin

Leuprorelin

arrow
Peptide Therapy Summit
Not Confirmed

Brand Name : Leuprorelin

arrow
Peptide Therapy Summit
Not Confirmed

Leuprorelin

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 1,005

2018 Revenue in Millions : 1,034

Growth (%) : -3

blank

10

Brand Name : Eligard

Leuprorelin

arrow
Peptide Therapy Summit
Not Confirmed

Brand Name : Eligard

arrow
Peptide Therapy Summit
Not Confirmed

Leuprorelin

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 117

2019 Revenue in Millions : 128

Growth (%) : -9

blank